Antimicrobial peptide and in combination with BAG shows a significant antimicrobial effect against S. mutans and, potentially, against S. epidermitis (ongoing work). This system is very promising to fight against implant infections with reduced chance of resistance development in pathogenic bacteria. NIH R21AR062249-02, KU #: NIH0071884 is greatly acknowledged.
展开▼